Activation of IL-11/STAT3 pathway in preconditioned human skeletal myoblasts blocks apoptotic cascade under oxidant stress

Regenerative Medicine

Volumn 7, Issue 1, 2012, Pages 47-57

  Idris, Niagara Muhammad ^a   Ashraf, Muhammad ^a   Ahmed, Rafeeq P H ^a   Shujia, Jiang ^a   Haider, Khawaja H ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

apoptosis; diazoxide; myoblasts; preconditioning

Indexed keywords

CYTOCHROME C; DIAZOXIDE; HYDROGEN PEROXIDE; INTERLEUKIN 11; LACTATE DEHYDROGENASE; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE B; SMALL INTERFERING RNA; STAT3 PROTEIN;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BIOLOGICAL THERAPY; CELL SURVIVAL; CELL ULTRASTRUCTURE; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME RELEASE; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IL11 GENE; IN VITRO STUDY; INTRACELLULAR SIGNALING; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION SWELLING; MYOBLAST; NICK END LABELING; OXIDATIVE STRESS; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; STEM CELL PRECONDITIONING;

ANNEXIN A5; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CYTOCHROMES C; CYTOPROTECTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IN SITU NICK-END LABELING; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-11; MEMBRANE POTENTIALS; MYOBLASTS, SKELETAL; OXIDANTS; PHOSPHORYLATION; PROPIDIUM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STAINING AND LABELING; STAT3 TRANSCRIPTION FACTOR; STRESS, PHYSIOLOGICAL; TIME FACTORS;

EID: 83655182222     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.11.109     Document Type: Article

References (36)

1. Dorner AJ, Goldman SJ, Keith JC Jr. Interleukin 11. BioDrugs 8, 418-429 (1997).
2. Kirkiles-Smith NC, Mahboubi K, Plescia J et al. IL 11 protects human microvascular endothelium from alloinjury in vivo by induction of survivin expression. J. Immunol. 172, 1391-1396 (2004). (Pubitemid 38116780)
3. Ropeleski MJ, Tang J, Walsh-Reitz MM, Musch MW, Chang EB. Interleukin 11-induced heat shock protein 25 confers intestinal epithelial-specific cytoprotection from oxidant stress. Gastroenterology 124, 1358-1368 (2003). (Pubitemid 36531810)
4. 2-induced cell death. Am. J. Respir. Cell. Mol. Biol. 29, 513-522 (2003). (Pubitemid 37222690)
5. Mahboubi K, Biedermann BC, Carroll JM, Pober JS. IL-11 activates human endothelial cells to resist immune-mediated injury. J. Immunol. 164, 3837-3846 (2000). (Pubitemid 30169842)
6. Haider HK, Idris NM, Kim HW, Ahmed RP, Shujia J, Ashraf M. MicroRNA 21 is a key determinant in IL 11/STAT-3 anti-apoptotic signaling pathway in preconditioning of skeletal myoblasts. Cardiovasc. Res. 88(1), 168-178 (2010).
7. Hagege AA, Marolleau JP, Vilquin JT et al. Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first Phase I cohort of patients. Circulation 114, I108-I113 (2006). (Pubitemid 44297137)
8. Tambara K, Sakakibara Y, Sakaguchi G et al. Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation 108(Suppl. 1), II259-II263 (2003). (Pubitemid 37099965)
9. Taylor DA, Atkins BZ, Hungspreugs P et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med. 4, 929-933 (1998). (Pubitemid 28364032)
10. + cells. Cell Transplant. 9, 489-502 (2000).
11. Smythe GM, Hodgetts SI, Grounds MD. Problems and solutions in myoblast transfer therapy. J. Cell. Mol. Med. 5, 33-47 (2001). (Pubitemid 33772982)
12. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J. Mol. Cell. Cardiol. 33, 907-921 (2001). (Pubitemid 32545326)
13. Pouzet B, Vilquin JT, Hagege AA et al. Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann. Thorac. Surg. 71, 844-850 (2001).
14. Niagara MI, Haider H, Jiang S, Ashraf M. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ. Res. 100, 545-555 (2007). (Pubitemid 46673264)
15. Jiang S, Haider H, Idris NM, Salim A, Ashraf M. Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair. Circ. Res. 99, 776-784 (2006). (Pubitemid 44498311)
16. Kim HW, Haider HKH, Shujia J, Ashraf M. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J. Biol. Chem. 284, 33161-33168 (2009).
17. Decker T, Kovarik P. Serine phosphorylation of STATs. Oncogene 19, 2628-2637 (2000). (Pubitemid 30339219)
18. Tenney R, Stansfield K, Pekala PH. Interleukin 11 signaling in 3T3-L1 adipocytes. J. Cell. Physiol. 202, 160-166 (2005). (Pubitemid 39603373)
19. Green DR, Reed JC. Mitochondria and apoptosis. Science 281, 1309-1312 (1998). (Pubitemid 28406816)
20. Haunstetter A, Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ. Res. 82, 1111-1129 (1998). (Pubitemid 28311120)
21. Azarnoush K, Maurel A, Sebbah L et al. Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1alpha. J. Thorac. Cardiovasc. Surg. 130, 173-179 (2005). (Pubitemid 40941687)
22. Christman KL, Vardanian AJ, Fang Q, Sievers RE, Fok HH, Lee RJ. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J. Am. Coll. Cardiol. 44, 654-660 (2004). (Pubitemid 39089073)
23. Tambara K, Premaratne GU, Sakaguchi G et al. Administration of control-released hepatocyte growth factor enhances the efficacy of skeletal myoblast transplantation in rat infarcted hearts by greatly increasing both quantity and quality of the graft. Circulation 112, I129-I134 (2005). (Pubitemid 41266664)
24. Bolli R. Preconditioning: a paradigm shift in the biology of myocardial ischemia. Am. J. Physiol. Heart Circ. Physiol. 292(1), H19-H27 (2006).
25. Akao M, Ohler A, O'Rourke B, Marban E. Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells. Circ. Res. 88, 1267-1275 (2001). (Pubitemid 32587843)
26. Han H, Long H, Wang H, Wang J, Zhang Y, Wang Z. Progressive apoptotic cell death triggered by transient oxidative insult in H9c2 rat ventricular cells: a novel pattern of apoptosis and the mechanisms. Am. J. Physiol. Heart Circ. Physiol. 286, H2169-H2182 (2004). (Pubitemid 38685231)
27. Caparrelli DJ, Cattaneo SM 2nd, Bethea BT et al. Pharmacological preconditioning ameliorates neurological injury in a model of spinal cord ischemia. Ann. Thorac. Surg. 74, 838-844 (2002).
28. Minners J, Lacerda L, McCarthy J, Meiring JJ, Yellon DM, Sack MN. Ischemic and pharmacological preconditioning in Girardi cells and C2C12 myotubes induce mitochondrial uncoupling. Circ. Res. 89, 787-792 (2001). (Pubitemid 34633849)
29. Patel HH, Gross GJ. Diazoxide induced cardioprotection: what comes first, K(ATP) channels or reactive oxygen species? Cardiovasc. Res. 51, 633-636 (2001). (Pubitemid 32800705)
30. Eliseev RA, Vanwinkle B, Rosier RN, Gunter TE. Diazoxide-mediated preconditioning against apoptosis involves activation of cAMP-response element-binding protein (CREB) and NFkB. J. Biol. Chem. 279, 46748-46754 (2004). (Pubitemid 39518323)
31. Kudo M, Wang Y, Xu M, Ayub A, Ashraf M. Adenosine A(1) receptor mediates late preconditioning via activation of PKC-delta signaling pathway. Am. J. Physiol. Heart Circ. Physiol. 283, H296-H301 (2002). (Pubitemid 34705351)
32. Rajapakse N, Shimizu K, Kis B, Snipes J, Lacza Z, Busija D. Activation of mitochondrial ATP-sensitive potassium channels prevents neuronal cell death after ischemia in neonatal rats. Neurosci. Lett. 327, 208-212 (2002). (Pubitemid 34756633)
33. Xu M, Wang Y, Ayub A, Ashraf M. Mitochondrial K(ATP) channel activation reduces anoxic injury by restoring mitochondrial membrane potential. Am. J. Physiol. Heart Circ. Physiol. 281, H1295-H1303 (2001).
34. Wang Y, Takashi E, Xu M, Ayub A, Ashraf M. Downregulation of protein kinase C inhibits activation of mitochondrial K(ATP) channels by diazoxide. Circulation 104, 85-90 (2001). (Pubitemid 32623294)
35. Arrell DK, Elliott ST, Kane LA et al. Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways. Circ. Res. 99, 706-714 (2006). (Pubitemid 44498304)
36. Kimura R, Maeda M, Arita A et al. Identification of cardiac myocytes as the target of interleukin 11, a cardioprotective cytokine. Cytokine 38, 107-115 (2007). (Pubitemid 47077909)